Table 3.
Correlation among the different questionnaires.
PHQ-P | HADSA-P | HADSD-P | MAXPS | PHQ-S | HADSA-S | HADSD-S | |
---|---|---|---|---|---|---|---|
PHQ-9-P | 1.000 | .288∗∗ | .385∗∗ | .599∗∗ | .78∗∗ | .229∗∗ | .434∗∗ |
HADSA- P | .288∗∗ | 1.000 | .241∗∗ | .472∗∗ | .463∗∗ | .86∗∗ | .580∗∗ |
HADSD-P | .385∗∗ | .241∗∗ | 1.000 | .174∗ | .313∗∗ | .025 | .103 |
MAX-PC | .599∗∗ | .472∗∗ | .174∗ | 1.000 | .555∗∗ | .070 | .358∗∗ |
PHQ-9 -S | .78∗∗ | .463∗∗ | .313∗∗ | .555∗∗ | 1.000 | .336∗∗ | .924∗∗ |
HADSA-S | .229∗∗ | 0.86∗∗ | .025 | .70∗∗ | .336∗∗ | 1.000 | .439∗∗ |
HADSD-S | .434∗∗ | .580∗∗ | .103 | .358∗∗ | .924∗∗ | .439∗∗ | 1.000 |
Spearman's rho. ∗∗The correlation is significant at the 0.01 level (bilateral). ∗The correlation is significant at the 0.05 level (bilateral). PHQ-9-P (PHQ-9 patients); PHQ-S (PHQ-9 spouses); HADSA-P (HADS anxiety, patients); HADSA-S (HADS anxiety, spouses); HADSD-P (HADS depression, patients); HADSD-S (HADS depression, spouses).